Regeneron President on Future of Health Care

The transcript discusses the challenges and future of the healthcare industry, focusing on the role of Regenerx, a biopharma company. It highlights the need for new medical breakthroughs to address rising healthcare costs due to diseases like Alzheimer's and diabetes. The discussion covers the balance between drug pricing and R&D investment, emphasizing the importance of long-term investment in research. The role of genetics in drug development is explored, showcasing Regenerx's success in creating new drugs. The need for industry incentives and regulatory support to foster innovation is also addressed.

What are the challenges faced in developing new drugs as mentioned in the text?

What is the speaker's perspective on the FDA's role in drug approval?

What role does genetics play in the future of healthcare according to the speaker?

How does the speaker propose to change the current drug pricing debate?